[go: up one dir, main page]

ES2173203T3 - Composicion que comprende una formulacion que actua contra las enfermedades sexualmente transmisibles y su utilizacion. - Google Patents

Composicion que comprende una formulacion que actua contra las enfermedades sexualmente transmisibles y su utilizacion.

Info

Publication number
ES2173203T3
ES2173203T3 ES95937526T ES95937526T ES2173203T3 ES 2173203 T3 ES2173203 T3 ES 2173203T3 ES 95937526 T ES95937526 T ES 95937526T ES 95937526 T ES95937526 T ES 95937526T ES 2173203 T3 ES2173203 T3 ES 2173203T3
Authority
ES
Spain
Prior art keywords
ets
composition
formulation
infectant
allows
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95937526T
Other languages
English (en)
Inventor
William Joseph Bologna
Howard Leslie Levine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Columbia Laboratories Bermuda Ltd
Original Assignee
Columbia Laboratories Bermuda Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Columbia Laboratories Bermuda Ltd filed Critical Columbia Laboratories Bermuda Ltd
Application granted granted Critical
Publication of ES2173203T3 publication Critical patent/ES2173203T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/14—Topical contraceptives and spermacides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA PRESENTE INVENCION PROPORCIONA UNA COMPOSICION Y USO DE UNA COMPOSICION QUE INCLUYE UNA FORMULACION POLIMERICA DE ACIDO POLICARBOXILICO DE ENLACE CRUZADO BIOADHESIVO QUE PERMITE EL USO DE CANTIDADES RELATIVAMENTE BAJAS DE AGENTES ANTI-STD COMO N-9, PARA SER USADOS EN LA PREVENCION DE LA INFECCION POR ETS SIN PROVOCAR LA IRRITACION DEL TEJIDO GENITAL QUE A MENUDO ACOMPAÑA A LAS DOSIS MAYORES DE ANTI-ETS. EL POLIMERO BIOADHESIVO MANTIENE UN CONTACTO MAYOR ENTRE EL AGENTE ANTI ETS Y EL INFECTANTE DURANTE UN PERIODO MUCHO MAYOR DE TIEMPO, PERMITIENDO CON UNA CONCENTRACION INFERIOR ACTUAR POR MAS TIEMPO SOBRE EL INFECTANTE, CUANDO SE COMPARA CON LAS APLICACIONES COMERCIALES NORMALMENTE DISPONIBLES QUE CONTIENEN N-9. TAL SUMINISTRO DA UNA SEGURIDAD Y PERMITE UNA DISMINUCION NO IRRITANTE EN EL RIESGO DE SUFRIR UNA INFECCION ETS, INCLUYENDO HIV.
ES95937526T 1994-10-07 1995-10-06 Composicion que comprende una formulacion que actua contra las enfermedades sexualmente transmisibles y su utilizacion. Expired - Lifetime ES2173203T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/319,495 US5667492A (en) 1994-10-07 1994-10-07 Use and composition of an anti-sexually transmitted diseases formulation

Publications (1)

Publication Number Publication Date
ES2173203T3 true ES2173203T3 (es) 2002-10-16

Family

ID=23242477

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95937526T Expired - Lifetime ES2173203T3 (es) 1994-10-07 1995-10-06 Composicion que comprende una formulacion que actua contra las enfermedades sexualmente transmisibles y su utilizacion.

Country Status (24)

Country Link
US (2) US5667492A (es)
EP (1) EP0784466B1 (es)
JP (1) JPH10507178A (es)
KR (1) KR970705976A (es)
AT (1) ATE213623T1 (es)
AU (1) AU704836B2 (es)
BR (1) BR9509280A (es)
CA (1) CA2201872A1 (es)
CO (1) CO4480018A1 (es)
DE (1) DE69525634T2 (es)
DK (1) DK0784466T3 (es)
ES (1) ES2173203T3 (es)
FI (1) FI971440L (es)
HU (1) HUT77527A (es)
IL (1) IL115495A0 (es)
MA (1) MA23687A1 (es)
MX (1) MX9504245A (es)
NO (1) NO971491L (es)
NZ (1) NZ295947A (es)
PE (1) PE46996A1 (es)
PT (1) PT784466E (es)
RU (1) RU2157184C2 (es)
WO (1) WO1996010989A1 (es)
ZA (1) ZA958434B (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005007194A1 (es) * 2003-07-16 2005-01-27 Italfarmaco, S.A. Formulaciones mucoadhesivas semisólidas

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6596777B1 (en) 1997-05-29 2003-07-22 Mcneil-Ppc, Inc. Moisture containing compositions that are spreadable onto and adherable to biomembranes
US6440980B1 (en) * 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
US5942243A (en) * 1996-11-12 1999-08-24 Polytherapeutics, Inc. Mucoadhesive compositions for administration of biologically active agents to animal tissue
WO1998051273A1 (en) * 1997-05-12 1998-11-19 Sage Pharmaceuticals, Inc. Topical spray for burn treatment and anti-infection
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
DE69819748T2 (de) * 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen
US20040234606A1 (en) * 1997-09-12 2004-11-25 Levine Howard L. Localized vaginal delivery without detrimental blood levels
EP1356806A1 (en) * 1997-09-12 2003-10-29 Columbia Laboratories (Bermuda) Limited A pharmaceutical composition for treating dysmenorrhea and premature labor
JP2002518351A (ja) 1998-06-19 2002-06-25 オキシバイオ・インコーポレイテッド 抗感染および避妊特性を有する医療装置
AU4489399A (en) * 1998-06-23 2000-01-10 Notax Holding Gesellschaft M.B.H. Use of nonoxynol-9 as lubricant and method for its production
US6159491A (en) * 1999-02-12 2000-12-12 Biovector Technologies, Inc. Prolonged release bioadhesive vaginal gel dosage form
US6818672B1 (en) 1999-10-05 2004-11-16 Columbia Laboratories, Inc. Treating endometriosis or infertility, or improving fertility
US6479045B2 (en) 1999-12-22 2002-11-12 Columbia Laboratories, Inc. Vaginal pH buffering for preventing miscarriage and premature labor, by treating or preventing bacterial vaginosis
PL202918B1 (pl) 2000-03-07 2009-08-31 Rush Presbyterian St Luke Przeciwbakteryjna i antykoncepcyjna kompozycja oraz jej zastosowanie
US7547433B2 (en) * 2001-02-15 2009-06-16 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
US7544348B2 (en) * 2001-02-15 2009-06-09 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
US20060073174A1 (en) * 2001-08-16 2006-04-06 Access Pharmaceuticals, Inc. Adherent and erodible film to treat a moist surface of a body tissue
US6585997B2 (en) 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
WO2003032915A2 (en) * 2001-10-16 2003-04-24 Avanir Pharmacueticals Viral inhibition by n-docosanol
US20030114394A1 (en) * 2001-10-29 2003-06-19 Levine Howard L. Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US8425892B2 (en) 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
CN101327326A (zh) * 2001-10-29 2008-12-24 哥伦比亚实验室(百慕大群岛)有限公司 阴道给药治疗骨盆痛和不孕症的抗节律障碍剂
US20080182841A1 (en) * 2001-10-29 2008-07-31 Levine Howard L Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US7709026B2 (en) * 2001-10-29 2010-05-04 Columbia Laboratories, Inc. Low concentration of peroxide for treating or preventing vaginal infections
RU2200572C1 (ru) * 2002-02-26 2003-03-20 Быков Валерий Алексеевич Комплекс природных соединений растительного происхождения, обладающий противоинфекционным действием в отношении инфекций, передаваемых половым путем
RU2200571C1 (ru) * 2002-02-26 2003-03-20 Быков Валерий Алексеевич Комплекс природных соединений растительного происхождения, активный в отношении вирусных и других инфекций, передаваемых половым путем
RU2200570C1 (ru) * 2002-02-26 2003-03-20 Быков Валерий Алексеевич Комплекс природных соединений растительного происхождения, обладающий сперматоцидным эффектом и активностью в отношении инфекций, передаваемых половым путем
EA011164B1 (ru) * 2003-02-07 2009-02-27 Янссен Фармацевтика Н. В. Производные пиримидина для профилактики вич-инфекции
ITMI20031640A1 (it) 2003-08-08 2005-02-09 Mipharm S P A Base per gel bioadesivi.
US12011423B2 (en) 2007-11-06 2024-06-18 Foraviset Ltd. S-alkylisothiouronium derivatives for treating uterine hypercontractility disorders
ES2344673B1 (es) 2008-08-07 2011-05-03 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farmaceutica parael tratamiento de atrofia vaginal en mujeres con riesgo de potologiatumoral.
ES2344675B1 (es) 2008-12-19 2011-04-28 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farrmaceutica para el tratamiento de atrofia vaginal en mujeres con riesgo de patologiacardiovascular.
WO2013187984A1 (en) * 2012-06-13 2013-12-19 Evofem, Inc. Compositions and methods for enhancing the efficacy of contraceptive microbicides
NZ722215A (en) 2013-12-19 2019-02-22 Evofem Inc Compositions and methods for inhibiting inflammation and diseases using an alginic acid-based antimicrobial compound
CN105250280B (zh) * 2014-07-14 2020-03-10 诺维科国际控股股份有限公司 包含辛苯聚醇和喹诺里西啶生物碱化合物或其来源的杀微生物组合物
AU2017338748A1 (en) 2016-10-04 2019-05-02 Evofem Inc. Method of treatment and prevention of bacterial vaginosis

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL265428A (es) * 1960-06-06
US4286593A (en) * 1980-05-05 1981-09-01 Place Virgil A Vaginal contraceptive shield
DE3278234D1 (en) * 1981-10-13 1988-04-21 Exovir Inc Interferon-containing compositions and the use of these compositions in the treatment of herpetic infections, pre-malignant skin lesions, skin malignancies and psoriasis
ATE151286T1 (de) * 1983-11-14 1997-04-15 Columbia Lab Inc Bioadhäsive mittel
US4983393A (en) * 1987-07-21 1991-01-08 Maximed Corporation Intra-vaginal device and method for sustained drug release
NO178843C (no) * 1988-07-11 1996-06-19 Sspl Sa Safe Sex Prod Licens Fremgangsmåte for fremstilling av et farmasöytisk preparat for å forhindre seksuelt overförbare sykdommer
US5000749A (en) * 1988-10-13 1991-03-19 Leveen Harry H Iodine contraceptive sponge
DE69033199T2 (de) * 1989-10-31 1999-10-28 Columbia Lab Bermuda Ltd Mittel zur feuchthaltung von gewebe und verfahren
DE69012955T2 (de) * 1989-10-31 1995-02-09 Columbia Laboratories, Inc., Miami, Fla. Verfahren zur Feuchthaltung von Gewebe und Mittel dazu.
DK0431719T3 (da) * 1989-10-31 1995-02-27 Columbia Lab Inc Vaginalt vævsbefugtende præparat
US5380523A (en) * 1993-08-17 1995-01-10 University Of Kentucky Research Foundation High energy coprecipitate of nonoxynol oligomer, PVP and iodine having contraceptive and potent anti-HIV properties

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005007194A1 (es) * 2003-07-16 2005-01-27 Italfarmaco, S.A. Formulaciones mucoadhesivas semisólidas
ES2237298A1 (es) * 2003-07-16 2005-07-16 Italfarmaco, S.A. Formulaciones mucoadhesivas semisolidas.
US8663688B2 (en) 2003-07-16 2014-03-04 Itf Research Pharma, S.L.U. Semi-solid mucoadhesive formulations

Also Published As

Publication number Publication date
AU704836B2 (en) 1999-05-06
US5667492A (en) 1997-09-16
IL115495A0 (en) 1996-01-19
NO971491D0 (no) 1997-04-02
BR9509280A (pt) 1997-11-18
PE46996A1 (es) 1996-11-23
ATE213623T1 (de) 2002-03-15
CO4480018A1 (es) 1997-07-09
JPH10507178A (ja) 1998-07-14
AU3961295A (en) 1996-05-02
RU2157184C2 (ru) 2000-10-10
CA2201872A1 (en) 1996-04-18
NO971491L (no) 1997-06-09
US20010006667A1 (en) 2001-07-05
FI971440A0 (fi) 1997-04-07
ZA958434B (en) 1996-05-08
EP0784466A1 (en) 1997-07-23
DK0784466T3 (da) 2002-04-22
FI971440A7 (fi) 1997-04-07
WO1996010989A1 (en) 1996-04-18
KR970705976A (ko) 1997-11-03
HUT77527A (hu) 1998-05-28
DE69525634D1 (de) 2002-04-04
DE69525634T2 (de) 2002-08-29
MX9504245A (es) 1997-01-31
PT784466E (pt) 2002-06-28
NZ295947A (en) 1999-02-25
FI971440L (fi) 1997-04-07
MA23687A1 (fr) 1996-07-01
EP0784466B1 (en) 2002-02-27

Similar Documents

Publication Publication Date Title
ES2173203T3 (es) Composicion que comprende una formulacion que actua contra las enfermedades sexualmente transmisibles y su utilizacion.
IT1251151B (it) Materiale spugnoso essenzialmente costituito da acido ialuronico,o suoi derivati
JP2988658B2 (ja) 非水性皮膚軟化剤入りヨードフォア製剤
US9687387B2 (en) System and methods for treating ear disorders
ES2176348T3 (es) Germicidas topicos con efecto acondicionador en forma de liquidos viscosos.
ES2159591T3 (es) Composicion de liberacion controlada.
ES2105332T3 (es) Polimeros quelantes.
ES2115733T3 (es) Composicion antialergica para uso oftalmico o nasal.
NO20011471D0 (no) Nye orale vedvarende frigivelsesformuleringer
BR9810084A (pt) Panos antimicrobianos
ATE455526T1 (de) Nicht-hormonales vaginales verhütungsmittel
PE3296A1 (es) Composicion oral conteniendo un mucoadhesivo
DE60109487D1 (de) Wasserfreier, hydrophiler absorbierender wundverband
ATE227976T1 (de) Lösungen als träger für augenarzneien
ES2071322T3 (es) Reduccion o prevencion de la irritacion de la piel por farmacos.
HRP20040480B1 (hr) Niska koncentracija peroksida za tretman i prevenciju vaginalnih infekcija
ES2152016T3 (es) Solucion oftalmica de pranoprofeno conteniendo amina organica.
WO1990008559A1 (en) Biodegradable disinfectant
US8518434B2 (en) Antiseptic spermicidal composition and means for its application
GT200000105A (es) Sal difosfato de un derivado de 4" - sustituido - 9 - desoxo - 9a - aza - 9a - homoeritromicina y sucomposicion farmaceutica.
CN117919102A (zh) 一种环保抗过敏免洗手消毒液
ES2063700B1 (es) Agente activo sobre el sistema nervioso central, proceso para su preparacion y composiciones farmaceuticas que lo contengan.
AR024654A1 (es) Composiciones de antibioticos de quinolona y uso de dichos antibioticos para la preparacion de dichas composiciones de aplicacion ocular en mamiferos.
ES2051643B1 (es) Formulaciones orales de ubidecarenona en forma de soluciones acuosas.
CO5580798A2 (es) Composicion de peroxido de liberacion prolongada para infecciones vaginales

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 784466

Country of ref document: ES